Grant: Engage Grants Program
University of Ottawa
$25,000.00
Pharmacoproteomics: Mass spectrometry based method development for mechanism of action
FY 2014-15
Summary
The study of drug effects is usually performed using a series of specific assays directed towards the drug target. For example, kinase inhibitors are screened against their targets and a panel of other kinases. The global effect of the drug at the cellular system level is often not studied and in particular not in the early stage of drug development. The cost and time associated with performing such global system studies are limiting factors. This is an interesting aspect of analytical biochemistry that is underdeveloped. Here we propose to develop an integrated analytical system that will allow rapid global study of the proteome in response to drug treatment (pharmacoproteomics). The system will combine technologies developed in the Figeys' laboratory that will allow pharmacoproteomic screening of one compound every six hours. Mass spectrometry will be used to identify and quantify 1000s of proteins while bioinformatics will be used to rapidly classify the proteins that change according to preset criteria. If successful, this pharmacoproteomic system would accelerate the study of the global effect(s) of drugs and be useful to our industrial partner for the rapid screening of their compounds.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
469821-2014
Name nom
Figeys, Daniel
Department département
Head Office
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Pharmacoproteomics: Mass spectrometry based method development for mechanism of action
Keyword
NSERC
Application summary
The study of drug effects is usually performed using a series of specific assays directed towards the drug target. For example, kinase inhibitors are screened against their targets and a panel of other kinases. The global effect of the drug at the cellular system level is often not studied and in particular not in the early stage of drug development. The cost and time associated with performing such global system studies are limiting factors. This is an interesting aspect of analytical biochemistry that is underdeveloped. Here we propose to develop an integrated analytical system that will allow rapid global study of the proteome in response to drug treatment (pharmacoproteomics). The system will combine technologies developed in the Figeys' laboratory that will allow pharmacoproteomic screening of one compound every six hours. Mass spectrometry will be used to identify and quantify 1000s of proteins while bioinformatics will be used to rapidly classify the proteins that change according to preset criteria. If successful, this pharmacoproteomic system would accelerate the study of the global effect(s) of drugs and be useful to our industrial partner for the rapid screening of their compounds.